Clinical Trials on Non-small Cell Lung Carcinoma (NSCLC) in Belgium
Total 415 results
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
AZ-VUBSanofiUnknownNon-Small-Cell Lung CarcinomaBelgium
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung Carcinoma NSCLCUnited States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Hasselt UniversityJessa Hospital; University Hospital, Ghent; University GhentRecruitingNon-small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
European Lung Cancer Working PartyCompletedNon Small Cell Lung CarcinomaBelgium
-
Daiichi Sankyo, Inc.CompletedNSCLC (Advanced Non-small Cell Lung Cancer)Ukraine, United Kingdom, United States, Bulgaria, Belgium, Germany, Hungary, Austria, Italy, Israel, Lithuania, Romania, Slovenia
-
Jules Bordet InstituteCompletedMetastatic Melanoma | Colorectal Cancer Metastatic | Metastatic Non-Small Cell Lung CarcinomaBelgium
-
Centre Hospitalier Universitaire de LiegeActive, not recruitingNon-small Cell Lung CancerBelgium
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
University Hospital, GhentHasselt University; Jessa Hospital; AZ Sint-Jan AV; AZ Delta; Ziekenhuis Oost-LimburgRecruitingNon Small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
Jules Bordet InstituteRecruitingNon Small Cell Lung CancerBelgium
-
AZ-VUBUnknownNon Small Cell Lung CarcinomaBelgium
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)Russian Federation, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Greece, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Sweden, Swit... and more
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung CancerBelgium
-
Universitair Ziekenhuis BrusselRecruitingNon Small Cell Lung CancerBelgium
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Universitair Ziekenhuis BrusselRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung Cancer MetastaticBelgium
-
University Hospital, GhentNationaal KankerplanTerminatedInoperable Early Stage Non-small Cell Lung CancerBelgium
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
European Lung Cancer Working PartyActive, not recruiting
-
Universitair Ziekenhuis BrusselRecruitingSolid Tumor | Non Small Cell Lung CancerBelgium
-
University Hospital, AntwerpSanofi; Universiteit AntwerpenCompletedNon-small Cell Lung CancerBelgium
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompletedNon-Small-Cell-Lung CancerBelgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorBelgium
-
Maastricht Radiation OncologyUniversitaire Ziekenhuizen KU LeuvenCompletedNon Small Cell Lung CancerNetherlands, Belgium
-
The Netherlands Cancer InstituteEuropean UnionActive, not recruitingNSCLCUnited Kingdom, Denmark, Netherlands, Sweden, Belgium
-
ETOP IBCSG Partners FoundationMirati Therapeutics Inc.RecruitingNSCLC Stage IV | KRAS P.G12CIreland, Italy, France, Spain, United Kingdom, Belgium
-
University Hospital, GhentNationaal KankerplanTerminatedEarly Stage Non-small Cell Lung CancerBelgium
-
Vrije Universiteit BrusselKom Op Tegen KankerUnknownLung Cancer, Non-small CellBelgium
-
University Hospital, AntwerpAstraZeneca; Universiteit AntwerpenCompletedNon Small Cell Lung CancerBelgium
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Centre Hospitalier Universitaire de LiegeRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GasthuisbergCompletedLung Cancer | Non Small Cell Lung CancerBelgium
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Spain, Poland, Japan, Belgium, Turkey, France, Korea, Republic of
-
European Organisation for Research and Treatment...Terminated
-
Universitair Ziekenhuis BrusselUnknownNon-Small Cell Lung CarcinomaBelgium
-
Eli Lilly and CompanyCompleted